|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 45.1 ILa | -2.80% |
|
+0.67% | +13.60% |
Clal Biotechnology Industries Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was ILS 0.104 million compared to ILS 0.37 million a year ago. Revenue was ILS 39.73 million compared to ILS 18.03 million a year ago.
Net loss was ILS 31.05 million compared to ILS 61.74 million a year ago. Basic loss per share from continuing operations was ILS 0.2. Basic loss per share was ILS 0.2 compared to ILS 0.39 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +13.60% | 18.83M | |
| +17.11% | 76.16B | |
| +58.67% | 17.61B | |
| +3.89% | 15.94B | |
| +8.12% | 14.05B | |
| -0.31% | 12.4B | |
| +9.49% | 12.06B | |
| +6.76% | 10.89B | |
| +37.06% | 10.34B | |
| -1.50% | 9.75B |
CLAL BIOTECHNOLOGY INDUSTRIES LTD. 
